210 related articles for article (PubMed ID: 25802056)
1. A humoral immune defect distinguishes the response to Staphylococcus aureus infections in mice with obesity and type 2 diabetes from that in mice with type 1 diabetes.
Farnsworth CW; Shehatou CT; Maynard R; Nishitani K; Kates SL; Zuscik MJ; Schwarz EM; Daiss JL; Mooney RA
Infect Immun; 2015 Jun; 83(6):2264-74. PubMed ID: 25802056
[TBL] [Abstract][Full Text] [Related]
2. Exacerbated
Farnsworth CW; Schott EM; Benvie A; Kates SL; Schwarz EM; Gill SR; Zuscik MJ; Mooney RA
J Immunol; 2018 Jul; 201(2):560-572. PubMed ID: 29858265
[TBL] [Abstract][Full Text] [Related]
3. Adaptive Upregulation of Clumping Factor A (ClfA) by Staphylococcus aureus in the Obese, Type 2 Diabetic Host Mediates Increased Virulence.
Farnsworth CW; Schott EM; Jensen SE; Zukoski J; Benvie AM; Refaai MA; Kates SL; Schwarz EM; Zuscik MJ; Gill SR; Mooney RA
Infect Immun; 2017 Jun; 85(6):. PubMed ID: 28320836
[TBL] [Abstract][Full Text] [Related]
4. Obesity/type 2 diabetes increases inflammation, periosteal reactive bone formation, and osteolysis during Staphylococcus aureus implant-associated bone infection.
Farnsworth CW; Schott EM; Benvie AM; Zukoski J; Kates SL; Schwarz EM; Gill SR; Zuscik MJ; Mooney RA
J Orthop Res; 2018 Jun; 36(6):1614-1623. PubMed ID: 29227579
[TBL] [Abstract][Full Text] [Related]
5. Modulation of Gut Microbiota Metabolism in Obesity-Related Type 2 Diabetes Reduces Osteomyelitis Severity.
Bui TI; Gill AL; Mooney RA; Gill SR
Microbiol Spectr; 2022 Apr; 10(2):e0017022. PubMed ID: 35315698
[TBL] [Abstract][Full Text] [Related]
6. A Diagnostic Serum Antibody Test for Patients With Staphylococcus aureus Osteomyelitis.
Nishitani K; Beck CA; Rosenberg AF; Kates SL; Schwarz EM; Daiss JL
Clin Orthop Relat Res; 2015 Sep; 473(9):2735-49. PubMed ID: 26013151
[TBL] [Abstract][Full Text] [Related]
7. Quantitative mouse model of implant-associated osteomyelitis and the kinetics of microbial growth, osteolysis, and humoral immunity.
Li D; Gromov K; Søballe K; Puzas JE; O'Keefe RJ; Awad H; Drissi H; Schwarz EM
J Orthop Res; 2008 Jan; 26(1):96-105. PubMed ID: 17676625
[TBL] [Abstract][Full Text] [Related]
8. Hyperglycemia inhibits complement-mediated immunological control of S. aureus in a rat model of peritonitis.
Mauriello CT; Hair PS; Rohn RD; Rister NS; Krishna NK; Cunnion KM
J Diabetes Res; 2014; 2014():762051. PubMed ID: 25610878
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal macrophages have an impaired immune response in obesity which can be reversed by subsequent weight loss.
Willemsen L; Neele AE; van der Velden S; Prange KHM; den Toom M; van Roomen CPAA; Reiche ME; Griffith GR; Gijbels MJJ; Lutgens E; de Winther MPJ
BMJ Open Diabetes Res Care; 2019; 7(1):e000751. PubMed ID: 31798899
[TBL] [Abstract][Full Text] [Related]
10. Monitoring immune responses in a mouse model of fracture fixation with and without Staphylococcus aureus osteomyelitis.
Rochford ETJ; Sabaté Brescó M; Zeiter S; Kluge K; Poulsson A; Ziegler M; Richards RG; O'Mahony L; Moriarty TF
Bone; 2016 Feb; 83():82-92. PubMed ID: 26525592
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcus aureus nasal carriage might be associated with vitamin D receptor polymorphisms in type 2 diabetes.
Messaritakis I; Samonis G; Dimopoulou D; Maraki S; Papadakis JA; Daraki V; Fragaki M; Choulaki C; Andrianaki AM; Kofteridis DP
Clin Microbiol Infect; 2014 Sep; 20(9):920-5. PubMed ID: 24517634
[TBL] [Abstract][Full Text] [Related]
12. Defects in innate immunity predispose C57BL/6J-Leprdb/Leprdb mice to infection by Staphylococcus aureus.
Park S; Rich J; Hanses F; Lee JC
Infect Immun; 2009 Mar; 77(3):1008-14. PubMed ID: 19103772
[TBL] [Abstract][Full Text] [Related]
13. Immune control of Staphylococcus aureus - regulation and counter-regulation of the adaptive immune response.
Bröker BM; Holtfreter S; Bekeredjian-Ding I
Int J Med Microbiol; 2014 Mar; 304(2):204-14. PubMed ID: 24462009
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of Immune Evasion and Bone Tissue Colonization That Make Staphylococcus aureus the Primary Pathogen in Osteomyelitis.
Muthukrishnan G; Masters EA; Daiss JL; Schwarz EM
Curr Osteoporos Rep; 2019 Dec; 17(6):395-404. PubMed ID: 31721069
[TBL] [Abstract][Full Text] [Related]
15. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
[TBL] [Abstract][Full Text] [Related]
16. Osteoblasts produce monocyte chemoattractant protein-1 in a murine model of Staphylococcus aureus osteomyelitis and infected human bone tissue.
Marriott I; Gray DL; Rati DM; Fowler VG; Stryjewski ME; Levin LS; Hudson MC; Bost KL
Bone; 2005 Oct; 37(4):504-12. PubMed ID: 16027056
[TBL] [Abstract][Full Text] [Related]
17. Blood-Retinal Barrier Compromise and Endogenous Staphylococcus aureus Endophthalmitis.
Coburn PS; Wiskur BJ; Astley RA; Callegan MC
Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7303-11. PubMed ID: 26559476
[TBL] [Abstract][Full Text] [Related]
18. The impact of TLR2 and aging on the humoral immune response to Staphylococcus aureus bacteremia in mice.
Gupta P; Hu Z; Kopparapu PK; Deshmukh M; Sághy T; Mohammad M; Jin T; Engdahl C
Sci Rep; 2023 May; 13(1):8850. PubMed ID: 37258615
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcus aureus mediastinitis and sternal osteomyelitis following median sternotomy in a rat model.
Barnea Y; Carmeli Y; Kuzmenko B; Navon-Venezia S
J Antimicrob Chemother; 2008 Dec; 62(6):1339-43. PubMed ID: 18799473
[TBL] [Abstract][Full Text] [Related]
20. IFN-gamma plays a detrimental role in murine defense against nasal colonization of Staphylococcus aureus.
Satorres SE; Alcaráz LE; Cargnelutti E; Di Genaro MS
Immunol Lett; 2009 Apr; 123(2):185-8. PubMed ID: 19428568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
